Gliknik's Series A - II Round

Gliknik raised a round of funding on August 14, 2009.

Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders. Gliknik's founders combine scientifi…

Articles about Gliknik's Series A - II Round: